Author

Michael J. Hall

Fox Chase Cancer CenterORCID 0000-0003-4515-3409Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:variant calling· 2 Assay:whole-exome sequencing· 2 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Elena V. DemidovaiD· 2 shared Erica A. GolemisiD· 2 shared Sanjeevani AroraiD· 2 shared Tiffiney R. HartmaniD· 2 shared Andrea D. FormaniD· 1 shared David Y.T. CheniD· 1 shared Ilya G. SerebriiskiiiD· 1 shared Lily HoangiD· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Elena V. DemidovaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintMay 23, 2022

Signatures of defective DNA repair and replication in early-onset renal cancer patients referred for germline genetic testing.

Elena V. Demidova, Ilya G. Serebriiskii, Ramilia Vlasenkova…·Sanjeevani Arora

The paper identifies DNA repair and replication defects in early-onset renal cancer patients without known germline variants, suggesting these defects contribute to cancer development and may inform treatment strategies.

DOI 10.1101/2022.05.23.22275227

humanwhole-exome sequencing

𝕏 PostBluesky

GeneticsScientific ReportsPeer-reviewedAug 11, 2020

Prevalence of pathogenic variants in DNA damage response genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer

Tiffiney R. Hartman, Elena V. Demidova, Randy W. Lesh…·Sanjeevani Arora

The paper examines the prevalence of pathogenic variants in DNA damage response genes in early-onset renal cancer patients undergoing genetic testing and finds that DDR gene variants are present in 8.55% of patients.

27 citations

humanDNA methylation

𝕏 PostBluesky